跳到正文
cccskills
免费在 GitHub 公开

es-pump-revert-to-manual

If CGM fails or is removed, revert the insulin pump to manual mode provided basic criteria for pump use in hospital are still met. Trigger phrase: "CGM failed, should we switch pump to manual mode?

中文简介正在准备中。当前显示原文说明。

查看安装方法

包含的文件(1)

  • SKILL.md2.7 KB

SKILL.md(原文)

安装前可以查看交给 AI 代理的指令内容。

Revert insulin pump to manual mode if CGM fails or is removed

STEP 1 — Gather Information

  • Confirm CGM failure or removal (sensor error, dislodgement, patient report).
  • Assess patient ability to self-manage pump (alert, competent, no impaired consciousness).
  • Verify absence of contraindications to pump use: not in ICU, no DKA/HHS, no severe hypoglycemia unawareness.
  • Ensure pump supplies (infusion sets, reservoirs, insulin) are available for duration of hospitalization.
  • Check hospital policies and availability of expertise for pump management.

STEP 2 — Rule In / Rule Out

  • Is CGM failed or removed?
    • Yes → proceed to Step 3.
    • No → continue pump with CGM-guided automation and routine POC-BG confirmation.

STEP 3 — Classify or Stratify

  • Are basic criteria for pump use in hospital still met?
    • Yes → proceed to Step 4 (revert to manual mode).
    • No → transition to scheduled subcutaneous basal bolus insulin therapy (see Table 3 for conversion).

STEP 4 — Decide

  • If criteria met: switch pump to manual mode (disable automated features, use pre-set basal rates and manual bolus calculations).
  • Order frequent POC-BG monitoring (e.g., every 4–6 hours or per institutional protocol) to guide manual dosing.
  • Document mode change and notify nursing/pharmacy.

Clinical Guardrails / Mimics / Pitfalls

  • Do not revert to manual mode if patient cannot safely adjust pump settings (e.g., altered mental status, delirium).
  • Avoid manual mode in patients with active DKA, HHS, or requiring vasopressors; transition to IV insulin instead.
  • Ensure backup glucose monitoring is in place; reliance on CGM alone is unsafe after failure.
  • Do not assume pump function is intact; verify infusion set integrity and insulin potency.
  • Pitfall: continuing automated pump modes with erroneous CGM data can cause hypoglycemia or hyperglycemia.

Concrete Clinical Example

A 62-year-old woman with type 1 diabetes on hybrid closed-loop pump admitted for cholecystectomy. On postoperative day 1, her CGM displays persistent "sensor error" alerts. She is alert, able to troubleshoot pump, has spare supplies, and no ICU stay. The team confirms CGM failure, verifies she meets pump-use criteria, reverts the pump to manual mode, and orders POC-BG checks every 6 hours.

Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问,或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护,适用 Google 的隐私权政策和服务条款。

同一仓库的技能

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题